The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Multiple Sclerosis Society UK
a/k/a: MS Society
372 Edgware Road
London, NW2 6ND
The Multiple Sclerosis Society UK is a non-profit organization dedicated to offering local and national services to individuals whose lives have been affected by multiple sclerosis (MS), and promoting and funding MS research. Multiple sclerosis is a progressive disease characterized by loss of myelin from nerve fibers within the brain and spinal cord (central nervous system). Myelin is a fatty substance that forms a protective, insulating sheath around certain nerve fibers, serving as an electrical insulator. The severity of MS may vary from case to case. Associated symptoms may include numbness, tingling, weakness, incoordination, visual abnormalities, and speech disturbances. The MS Society was established in 1953 and currently consists of approximately 350 UK branches, and 45,000 members across Great Britain and Northern Ireland. The society offers a variety of services and programs including telephone counseling, financial assistance for affected individuals, respite and holiday centers, residential and day centers, and transportation assistance. In addition, the MS Society is committed to funding biomedical research; supporting applied research to improve the lives of affected individuals; working with other charities that serve people with MS; lobbying for equitable prescribing and funding of therapies; and improving statutory services by educating professionals about MS.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.